Inotek Pharmaceuticals
»  Home »  Contact »  Site Map



Technology Overview

Adenosine

Peroxynitrite

Flagellin

PARP

Publications

Adenosine publications

Peroxynitrite publications

Flagellin publications

PARP publications

Other Inotek publications


Inotek's Adenosine Publications

 

2004

Jagtap P, Chen Z, Szabó C, Klotz K. 2004.   2-(N-Acyl) and 2-N-acyl-N6-substituted analogues of adenosine and their affinity at the human adenosine receptors.  Bioorganic & Medicinal Chemistry Letters 14:1495-1498

 

2003

Mabley JG, Soriano FG, Pacher P, Haskó G, Marton A, Wallace R, Salzman AL, Szabó C. 2003. The adenosine A3 receptor agonist N6-(3-iodobenzyl)-adenosine-5’-N-methyluronamide, reduces inflammation and oxidative damage in two murine models of colitis.  Eur J Pharmacol, 466:323-329.

 

Németh Z, Leibovich J, Deitch EA, Vizi SE, Szabó C, Haskó G. 2003. cDNA microarray analysis reveals a NF-kB- independent regulation of macrophage function by adenosine. J Pharmacol Exp Ther 306: 1042-1049.

 

Németh Z, Leibovich S, Deitch E, Sperlagh B, Virag L, Vizi E, Szabó C, Haskó G. 2003. Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediatd mechanism. Biochemical & Biophysical Research Communications 312: 883-888.

 

Pinhal-Enfield G, Ramanathan M, Haskó G, Vogel SN, Salzman AL, Boons GJ, Leibovich SJ. 2003. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 163:711-21.

 

2002

Haskó G, Deitch EA, Szabó C, Németh ZH, Vizi ES. 2002. Adenosine: a potential mediator of immunosuppression in multiple organ failure.  Current Opinion in Pharmacology 2:440-444.

 

1999

Haskó G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, Marton A, Szabó C. 1999. Adenosine inhibits IL-12 and TNF-a production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 14:2065-74.

 

Haskó G, Németh ZH, Salzman AL, Vizi ES, Szabó C. 1999. An agonist of A3 adenosine receptors decreases IL-12, IFN and nitric oxide production and prevents lethality in endotoxemic mice. Eur J Pharmacol 358:261-268.

 

1998

Szabó C, Scott GS, Virág L, Egnaczyk G, Salzman AL, Shanley TP, Haskó G. 1998. Suppression of macrophage inflammatory protein (MIP)-1 alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 125:379-387.

 

1996

Haskó G, Szabó C, Németh ZH, Kvetan V, Pastores SM, Vizi ES. 1996. Adenosine receptor agonists differentially regulate IL-10 and TNF production in endotoxemic mice. J Immunol 157:4634-4640.

 

Small Business Web Design
Copyright © Inotek Pharmaceuticals Corporation 2000 - 2008 » Site Map